• masa_aleckovic

Jenn receives the Ruth L. Kirschstein National Research Service Award (NRSA)

Jenn Ge, a graduate student in the Polyak lab, was awarded the Ruth L. Kirschstein National Research Service Award to evaluate optimal BET inhibitor combination therapies in triple negative breast cancer (TNBC). The latter is an aggressive subtype of breast cancer that currently lacks options for targeted therapy. BET inhibitor therapy is a promising therapeutic agent in TNBC, but development of resistance necessitates identification and optimization of combination therapies, as well as a better understanding of treatment response. Jenn’s proposed research will establish how to optimally combine BET inhibitors with chemotherapy and immunotherapy and will have direct translational impact in informing the rational design of clinical trial.



264 views
Contact

Dana-Farber Cancer Institute

450 Brookline Ave. SM-1070

Boston, MA 02215

​​

Tel: (617) 632-(2106)​

kornelia_polyak@dfci.harvard.edu

claudia_steele@dfci.harvard.edu

Mission

The Polyak Lab is dedicated to the molecular analysis of human breast cancer